| Sarah Bernabe-cullen, RN, BSN | |
|
72 67th St, West New York, NJ 07093-4308 | |
| (201) 759-1263 | |
| Not Available |
| Full Name | Sarah Bernabe-cullen |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 72 67th St, West New York, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538503156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 22 367554 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Bernabe-cullen, RN, BSN 72 67th St, West New York, NJ 07093-4308 Ph: (201) 759-1263 | Sarah Bernabe-cullen, RN, BSN 72 67th St, West New York, NJ 07093-4308 Ph: (201) 759-1263 |
News Archive
SAGE is pleased to announce that it will begin publishing Veterinary Pathology, a key international journal of natural and experimental disease, beginning in 2010.
An army of doctors, nurses, dentists and other health workers on Thursday began providing free care to a steady stream of patients at the annual Care Harbor clinic at the Los Angeles Memorial Sports Arena. Care Harbor founder Don Manelli estimated that 700 to 800 people would receive free care by the end of the day Thursday. In all, the clinic expects to serve about 4,000 Angelenos-many of whom don't have insurance, or don't have coverage for services like dentistry or vision care (Brown, 10/31).
According to a new report babies in the United States have a higher risk of dying during their first month of life than do babies born in 40 other countries. Some of the countries that outrank the United States in terms of newborn death risk are South Korea, Cuba, Malaysia, Lithuania, Poland and Israel, according to the study.
More than a decade of research on the mda-7/IL-24 gene has shown that it helps to suppress a majority of cancer types, and now scientists are focusing on how the gene drives this process by influencing microRNAs.
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 3 days ago
Mr. Dino Pascual, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 Port Imperial Avenue, Apt. 111, West New York, NJ 07093 Phone: 213-568-5627 | |
Ms. Inverness Marie Howard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 318 54th St, Suite 4e, West New York, NJ 07093 Phone: 201-431-6088 | |
Diana Terry, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7000 Boulevard E Apt 20a, West New York, NJ 07093 Phone: 718-541-7496 | |
Yoel Cuba-pacheco, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6135 Bergenline Ave Ste 4, West New York, NJ 07093 Phone: 609-857-2296 Fax: 609-857-2295 |